Hunter C. Smith

Insider Reports History

Location
Boston, MA
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Hunter C. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hunter C. Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
RHYTHM PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 116,915 $11,223,840 $96.00 13 Aug 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Chief Financial Officer Restricted Stock Units 19,800 $1,132,956 $57.22 16 Feb 2025 Direct
Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy) 1,950,000 22 Jun 2023 Direct
RHYTHM PHARMACEUTICALS, INC. Chief Financial Officer Stock Options (Right to Buy) 0 13 Aug 2025 Direct

Insider Reports Filed by Hunter C. Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RYTM RHYTHM PHARMACEUTICALS, INC. 12 Aug 2025 6 -$2,511,378 4 Chief Financial Officer 14 Aug 2025, 18:48
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Jul 2025 5 -$3,099,971 4 Chief Financial Officer 11 Jul 2025, 16:31
RYTM RHYTHM PHARMACEUTICALS, INC. 07 Jul 2025 2 +$48,064 4 Chief Financial Officer 08 Jul 2025, 16:30
RYTM RHYTHM PHARMACEUTICALS, INC. 30 May 2025 4 -$1,276,018 4 Chief Financial Officer 03 Jun 2025, 16:15
RYTM RHYTHM PHARMACEUTICALS, INC. 14 Feb 2025 5 -$126,742 4 Chief Financial Officer 19 Feb 2025, 21:50
RYTM RHYTHM PHARMACEUTICALS, INC. 12 Feb 2025 2 -$42,347 4 Chief Financial Officer 14 Feb 2025, 16:59
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Feb 2025 6 -$74,533 4 Chief Financial Officer 11 Feb 2025, 21:44
RYTM RHYTHM PHARMACEUTICALS, INC. 01 Feb 2025 3 -$99,724 4 Chief Financial Officer 04 Feb 2025, 21:27
RYTM RHYTHM PHARMACEUTICALS, INC. 19 Mar 2024 1 -$608,498 4 Chief Financial Officer 19 Mar 2024, 20:57
RYTM RHYTHM PHARMACEUTICALS, INC. 16 Feb 2024 3 $0 4 Chief Financial Officer 21 Feb 2024, 19:01
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Feb 2024 6 -$97,441 4 Chief Financial Officer 13 Feb 2024, 20:50
RYTM RHYTHM PHARMACEUTICALS, INC. 01 Feb 2024 3 -$72,817 4 Chief Financial Officer 05 Feb 2024, 18:54
RYTM RHYTHM PHARMACEUTICALS, INC. 29 Dec 2023 2 +$72,240 4 Chief Financial Officer 03 Jan 2024, 16:15
RYTM RHYTHM PHARMACEUTICALS, INC. 05 Dec 2023 6 -$860,421 4 Chief Financial Officer 07 Dec 2023, 16:16
RYTM RHYTHM PHARMACEUTICALS, INC. 24 Nov 2023 3 -$308,835 4 Chief Financial Officer 28 Nov 2023, 16:05
RYTM RHYTHM PHARMACEUTICALS, INC. 14 Nov 2023 3 -$282,013 4 Chief Financial Officer 16 Nov 2023, 16:05
AGLE Aeglea BioTherapeutics, Inc. 22 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:31
RYTM RHYTHM PHARMACEUTICALS, INC. 16 Jun 2023 2 +$13,760 4 Chief Financial Officer 21 Jun 2023, 16:05
RYTM RHYTHM PHARMACEUTICALS, INC. 11 Feb 2023 3 -$18,863 4 Chief Financial Officer 14 Feb 2023, 19:59
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Feb 2023 1 -$38,872 4/A Chief Financial Officer 14 Feb 2023, 18:08
RYTM RHYTHM PHARMACEUTICALS, INC. 01 Feb 2023 2 $0 4 Chief Financial Officer 03 Feb 2023, 15:09
RYTM RHYTHM PHARMACEUTICALS, INC. 23 Dec 2022 1 $0 4 Chief Financial Officer 29 Dec 2022, 15:31
RYTM RHYTHM PHARMACEUTICALS, INC. 30 Jun 2022 3 -$30,792 4 Chief Financial Officer 06 Jul 2022, 18:08
AGLE Aeglea BioTherapeutics, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 21:19
RYTM RHYTHM PHARMACEUTICALS, INC. 11 Feb 2022 3 -$5,081 4 Chief Financial Officer 15 Feb 2022, 18:31
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Feb 2022 2 $0 4 Chief Financial Officer 11 Feb 2022, 20:35
AGLE Aeglea BioTherapeutics, Inc. 12 Nov 2021 1 $0 4 Director 16 Nov 2021, 15:34
AGLE Aeglea BioTherapeutics, Inc. 12 Nov 2021 0 $0 3 Director 16 Nov 2021, 15:32